Daniil Gataulin
Stock Analyst at Chardan Capital
(3.63)
# 787
Out of 4,944 analysts
98
Total ratings
47.78%
Success rate
7.28%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Daniil Gataulin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRVO CervoMed | Maintains: Buy | $15 | $9.37 | +60.07% | 7 | Aug 11, 2025 | |
| RGNX REGENXBIO | Maintains: Buy | $52 | $9.13 | +469.55% | 12 | Aug 8, 2025 | |
| CGTX Cognition Therapeutics | Maintains: Buy | $4 | $1.25 | +220.00% | 8 | Aug 8, 2025 | |
| EYPT EyePoint Pharmaceuticals | Maintains: Buy | $27 | $11.13 | +142.70% | 12 | Aug 7, 2025 | |
| OCGN Ocugen | Maintains: Buy | $7 | $1.05 | +566.67% | 13 | Aug 4, 2025 | |
| QURE uniQure | Maintains: Buy | $38 → $35 | $14.64 | +139.07% | 5 | Jul 29, 2025 | |
| CLSD Clearside Biomedical | Downgrades: Neutral | n/a | $0.44 | - | 5 | Jul 18, 2025 | |
| FBRX Forte Biosciences | Maintains: Buy | $61 | $10.80 | +464.81% | 5 | Jun 24, 2025 | |
| ADVM Adverum Biotechnologies | Maintains: Buy | $33 | $2.56 | +1,191.59% | 7 | May 15, 2025 | |
| MGTX MeiraGTx Holdings | Maintains: Buy | $38 → $35 | $8.35 | +319.16% | 4 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $28 → $33 | $18.13 | +82.02% | 7 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $70 | $22.51 | +210.97% | 2 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3 | $2.15 | +39.53% | 8 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $220 | $2.21 | +9,877.32% | 1 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $8.49 | - | 2 | Jul 25, 2023 |
CervoMed
Aug 11, 2025
Maintains: Buy
Price Target: $15
Current: $9.37
Upside: +60.07%
REGENXBIO
Aug 8, 2025
Maintains: Buy
Price Target: $52
Current: $9.13
Upside: +469.55%
Cognition Therapeutics
Aug 8, 2025
Maintains: Buy
Price Target: $4
Current: $1.25
Upside: +220.00%
EyePoint Pharmaceuticals
Aug 7, 2025
Maintains: Buy
Price Target: $27
Current: $11.13
Upside: +142.70%
Ocugen
Aug 4, 2025
Maintains: Buy
Price Target: $7
Current: $1.05
Upside: +566.67%
uniQure
Jul 29, 2025
Maintains: Buy
Price Target: $38 → $35
Current: $14.64
Upside: +139.07%
Clearside Biomedical
Jul 18, 2025
Downgrades: Neutral
Price Target: n/a
Current: $0.44
Upside: -
Forte Biosciences
Jun 24, 2025
Maintains: Buy
Price Target: $61
Current: $10.80
Upside: +464.81%
Adverum Biotechnologies
May 15, 2025
Maintains: Buy
Price Target: $33
Current: $2.56
Upside: +1,191.59%
MeiraGTx Holdings
May 14, 2025
Maintains: Buy
Price Target: $38 → $35
Current: $8.35
Upside: +319.16%
May 9, 2025
Maintains: Buy
Price Target: $28 → $33
Current: $18.13
Upside: +82.02%
May 5, 2025
Maintains: Buy
Price Target: $70
Current: $22.51
Upside: +210.97%
Feb 18, 2025
Maintains: Neutral
Price Target: $3
Current: $2.15
Upside: +39.53%
Mar 7, 2024
Maintains: Buy
Price Target: $220
Current: $2.21
Upside: +9,877.32%
Jul 25, 2023
Downgrades: Neutral
Price Target: n/a
Current: $8.49
Upside: -